Research ArticleArticle
Human Immunodeficiency Virus Protease Inhibitors Interact with ATP Binding Cassette Transporter 4/Multidrug Resistance Protein 4: A Basis for Unanticipated Enhanced Cytotoxicity
Yu Fukuda, Kazumasa Takenaka, Alex Sparreboom, Satish B. Cheepala, Chung-Pu Wu, Sean Ekins, Suresh V. Ambudkar and John D. Schuetz
Molecular Pharmacology September 2013, 84 (3) 361-371; DOI: https://doi.org/10.1124/mol.113.086967
Yu Fukuda
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.F., K.T., A.S., S.B.C., J.D.S.); Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.-P.W., S.V.A.); and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.)
Kazumasa Takenaka
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.F., K.T., A.S., S.B.C., J.D.S.); Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.-P.W., S.V.A.); and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.)
Alex Sparreboom
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.F., K.T., A.S., S.B.C., J.D.S.); Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.-P.W., S.V.A.); and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.)
Satish B. Cheepala
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.F., K.T., A.S., S.B.C., J.D.S.); Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.-P.W., S.V.A.); and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.)
Chung-Pu Wu
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.F., K.T., A.S., S.B.C., J.D.S.); Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.-P.W., S.V.A.); and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.)
Sean Ekins
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.F., K.T., A.S., S.B.C., J.D.S.); Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.-P.W., S.V.A.); and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.)
Suresh V. Ambudkar
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.F., K.T., A.S., S.B.C., J.D.S.); Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.-P.W., S.V.A.); and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.)
John D. Schuetz
Department of Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee (Y.F., K.T., A.S., S.B.C., J.D.S.); Laboratory of Cell Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland (C.-P.W., S.V.A.); and Collaborations in Chemistry, Fuquay-Varina, North Carolina (S.E.)

Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
HIV Protease Inhibitors and MRP4
Yu Fukuda, Kazumasa Takenaka, Alex Sparreboom, Satish B. Cheepala, Chung-Pu Wu, Sean Ekins, Suresh V. Ambudkar and John D. Schuetz
Molecular Pharmacology September 1, 2013, 84 (3) 361-371; DOI: https://doi.org/10.1124/mol.113.086967